Is Eli Lilly Stock (LLY) Halal? A Complete Analysis

The Short Answer

Eli Lilly stock (LLY) is generally considered halal by most Islamic scholars and Sharia screening agencies. Pharmaceutical drug development and manufacturing is clearly permissible — and even encouraged — in Islam, as it serves the preservation of life (hifz al-nafs), one of the five objectives of Sharia (Maqasid al-Shariah).

Eli Lilly passes all standard Sharia financial screens, has no haram revenue sources, and its core mission of treating disease is strongly aligned with Islamic values.

Sharia Screening Methodology

Islamic scholars use several criteria to screen stocks:

• Business activity screen: Is the company's primary business halal?
• Debt ratio: Total debt / market cap must be under 33%
• Interest income: Interest income / total revenue must be under 5%
• Haram revenue: Revenue from haram sources must be under 5%
• Receivables ratio: Total receivables / total assets must be under 49–70% (varies by board)

Eli Lilly's Business Activity

Eli Lilly is one of the world's largest pharmaceutical companies. It discovers, develops, manufactures, and sells prescription medicines globally. Key products include:

• Mounjaro and Zepbound (tirzepatide — GLP-1 for diabetes and obesity)
• Jardiance (empagliflozin — type 2 diabetes)
• Trulicity (dulaglutide — type 2 diabetes)
• Taltz (ixekizumab — psoriasis and arthritis)
• Verzenio (abemaciclib — breast cancer)
• Donanemab (Alzheimer's disease)

Drug development and manufacturing is entirely permissible in Islamic law. The Prophet Muhammad (peace be upon him) encouraged seeking treatment: "Make use of medical treatment, for Allah has not made a disease without appointing a remedy for it" (Abu Dawud).

Financial Ratios (2025)

Based on Eli Lilly's most recent financial statements:

• Total Debt / Market Cap: ~6% ✅ (threshold: under 33%)
• Interest Income / Revenue: ~0.5% ✅ (threshold: under 5%)
• Haram Revenue: None identified ✅
• Receivables Ratio: Within limits ✅

Eli Lilly passes all four key Sharia financial screens comfortably.

Concerns to Be Aware Of

1. Drug Pricing Controversies

Eli Lilly, like many pharmaceutical companies, has faced criticism for high drug prices — particularly for insulin and GLP-1 medications. This is an ethical debate but not a Sharia disqualifier. Lilly has taken steps to cap insulin prices at $35/month for many patients.

2. Animal Testing

Drug development involves animal testing, which is widely accepted as a necessary part of medical research. Islamic scholars generally permit this as a necessity (darura) given the life-saving benefits.

3. Interest Income (Minor)

Eli Lilly earns some interest on its cash holdings. This represents less than 1% of revenue. Purification is advisable.

Action required: Donate approximately 0.5–1% of any LLY dividends to charity as purification.

Verdict from Major Screening Agencies

Eli Lilly stock is screened as compliant (halal) by:

• MSCI Islamic Index — Included ✅
• Dow Jones Islamic Market Index — Included ✅
• Zoya App — Compliant ✅
• Amana Funds (Saturna Capital) — Held in portfolio ✅

Bottom Line

Eli Lilly (LLY) is generally halal for Muslim investors. Pharmaceutical development is explicitly aligned with Islamic values around preserving life, the company passes all Sharia financial screens, and there are no haram revenue sources. A minimal purification amount for interest income is advisable.

Lilly's position in the GLP-1 obesity and diabetes drug revolution makes it one of the most significant healthcare investments of this decade — and it's a clean choice from a Sharia perspective.